Hypoglycemia in Insulin-Treated Diabetes: A Case for Increased Vigilance

References

• . The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–986
   PubMed Web of Science ®Google Scholar
• . Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332(7533):73–78
   PubMed Web of Science ®Google Scholar
• . Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229–234
   PubMed Web of Science ®Google Scholar
• . UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853
   PubMed Web of Science ®Google Scholar
• . Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359(15):1577–1589
   PubMed Web of Science ®Google Scholar
• . Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358(6):580–591
   PubMed Web of Science ®Google Scholar
• . Heinemann L. Overcoming obstacles: new management options. Eur J Endocrinol. 2004;151( suppl 2):T23–T7
   PubMed Web of Science ®Google Scholar
• . Evans JM, Newton RW, Ruta DA, MacDonald TM, Stevenson RJ, Morris AD. Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database. BMJ. 1999;319(7202):83–86
   PubMed Web of Science ®Google Scholar
• . Di Battista AM, Hart TA, Greco L, Gloizer J. Type 1 diabetes among adolescents: reduced diabetes self-care caused by social fear and fear of hypoglycemia. Diabetes Educ. 2009;35(3):465–475
   PubMed Web of Science ®Google Scholar
• . Morris AD, Boyle DI, McMahon AD, Greene SA, MacDonald TM, Newton RW. Adherence to insulin treatment, glycaemic control, and ketoacidosis in insulin-dependent diabetes. The DARTS/MEMO Collaboration. Diabetes Audit and Research in Tayside Scotland. Medicines Monitoring Unit. Lancet. 1997;350(9090):1505–1510
   PubMed Web of Science ®Google Scholar
• . Smith CB, Choudhary P, Pernet A, Hopkins D, Amiel SA. Hypoglycemia unawareness is associated with reduced adherence to therapeutic decisions in patients with type 1 diabetes: evidence from a clinical audit. Diabetes Care. 2009;32(7):1196–1198
   PubMed Web of Science ®Google Scholar
• . Moreland EC, Volkening LK, Lawlor MT, Chalmers KA, Anderson BJ, Laffel LM. Use of a blood glucose monitoring manual to enhance monitoring adherence in adults with diabetes: a randomized controlled trial. Arch Intern Med. 2006;166(6):689–695
   PubMedGoogle Scholar
• . Self-monitoring of blood glucose among adults with diabetes–United States, 1997–2006. MMWR Morb Mortal Wkly Rep. 2007;56(43):1133–1137
   PubMedGoogle Scholar
• . Brindisi MC, Hahn J, Chiasson JL, Rabasa-Lhoret R. Under-utilization of capillary glucose monitoring by type 2 diabetic patients. Diabetes Res Clin Pract. 2007;75(1):123–125
   PubMed Web of Science ®Google Scholar
• . Cryer PE. Hypoglycemia: still the limiting factor in the glycemic management of diabetes. Endocr Pract. 2008;14(6):750–756
   PubMedGoogle Scholar
• . Cryer PE. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med. 2004;350(22):2272–2279
   PubMed Web of Science ®Google Scholar
• . Riddle MC. The underuse of insulin therapy in North America. Diabetes Metab Res Rev. 2002;18( suppl 3):S42–S49
   PubMed Web of Science ®Google Scholar
• . Anderbro T, Amsberg S, Adamson U,. Fear of hypoglycaemia in adults with type 1 diabetes. Diabet Med. 2010;27(10):1151–1158
   PubMed Web of Science ®Google Scholar
• . Buse JB, Bigger JT, Byington RP,. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol. 2007;99(12 A):21i–33i
   Google Scholar
• . Raju B, Cryer PE. Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans. Diabetes. 2005;54(3):757–764
   PubMed Web of Science ®Google Scholar
• . Pedersen-Bjergaard U, Pramming S, Heller SR,. Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection. Diabetes Metab Res Rev. 2004;20(6):479–486
   PubMed Web of Science ®Google Scholar
• . ter Braak EW, Appelman AM, van de LM, Stolk RP, van Haeften TW, Erkelens DW. Clinical characteristics of type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care. 2000;23(10):1467–1471
   PubMed Web of Science ®Google Scholar
• . Bulsara MK, Holman CD, Davis EA, Jones TW. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabetes Care. 2004;27(10):2293–2298
   PubMed Web of Science ®Google Scholar
• . Bode BW, Steed RD, Davidson PC. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type I diabetes. Diabetes Care. 1996;19(4):324–327
   PubMed Web of Science ®Google Scholar
• . Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care. 1999;22(11):1779–1784
   PubMed Web of Science ®Google Scholar
• . Jeha GS, Karaviti LP, Anderson B,. Insulin pump therapy in preschool children with type 1 diabetes mellitus improves glycemic control and decreases glucose excursions and the risk of hypoglycemia. Diabetes Technol Ther. 2005;7(6):876–884
   PubMedGoogle Scholar
• . Kaufman FR, Halvorson M, Miller D, Mackenzie M, Fisher LK, Pitukcheewanont P. Insulin pump therapy in type 1 pediatric patients: now and into the year 2000. Diabetes Metab Res Rev. 1999;15(5):338–352
   PubMed Web of Science ®Google Scholar
• . Berthe E, Lireux B, Coffin C,. Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure. Horm Metab Res. 2007;39(3):224–229
   PubMed Web of Science ®Google Scholar
• . Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB,. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care. 2003;26(9):2598–2603
   PubMed Web of Science ®Google Scholar
• . Pickup JC, Sutton AJ. Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med. 2008;25(7):765–774
   PubMed Web of Science ®Google Scholar
• . Abraira C, Colwell JA, Nuttall FQ,. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care. 1995;18(8):1113–1123
   PubMed Web of Science ®Google Scholar
• . Gurlek A, Erbaş T, Gedik O. Frequency of severe hypoglycaemia in type 1 and type 2 diabetes during conventional insulin therapy. Exp Clin Endocrinol Diabetes. 1999;107(3):220–324
   PubMed Web of Science ®Google Scholar
• . Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med. 2003;20(12):1016–1021
   PubMed Web of Science ®Google Scholar
• . Macleod KM, Hepburn DA, Frier BM. Frequency and morbidity of severe hypoglycaemia in insulin-treated diabetic patients. Diabet Med. 1993;10(3):238–245
   PubMed Web of Science ®Google Scholar
• . Murata GH, Duckworth WC, Shah JH, Wendel CS, Mohler MJ, Hoffman RM. Hypoglycemia in stable, insulin-treated veterans with type 2 diabetes: a prospective study of 1662 episodes. J Diabetes Complications. 2005;19(1):10–17
   PubMed Web of Science ®Google Scholar
• . Ohkubo Y, Kishikawa H, Araki E,. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103–117
   PubMed Web of Science ®Google Scholar
• . Saudek CD, Duckworth WC, Giobbie-Hurder A,. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group. JAMA. 1996;276(16):1322–1327
   PubMed Web of Science ®Google Scholar
• . Yki-Jarvinen H, Ryysy L, Nikkila K, Tulokas T, Vanamo R, Heikkila M. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1999;130(5):389–396
   PubMed Web of Science ®Google Scholar
• . Hepburn DA, Macleod KM, Pell AC, Scougal IJ, Frier BM. Frequency and symptoms of hypoglycaemia experienced by patients with type 2 diabetes treated with insulin. Diabet Med. 1993;10(3):231–237
   PubMed Web of Science ®Google Scholar
• . Holstein A, Plaschke A, Egberts EH. Clinical characterisation of severe hypoglycaemia—a prospective population-based study. Exp Clin Endocrinol Diabetes. 2003;111(6):364–369
   PubMed Web of Science ®Google Scholar
• . Leese GP, Wang J, Broomhall J,; DARTS/MEMO Collaboration. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use. Diabetes Care. 2003;26(4):1176–1180
   PubMed Web of Science ®Google Scholar
• . Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2008. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf. Accessed January 20, 2011
   Google Scholar
• . Heaton B, Martin S, Brelje T. The economic effect of hypoglycemia in a health plan. Manag Care Interface. 2003;16(7):23–27
   PubMedGoogle Scholar
• . Rhoads GG, Orsini LS, Crown W, Wang S, Getahun D, Zhang Q. Contribution of hypoglycemia to medical care expenditures and short-term disability in employees with diabetes. J Occup Environ Med. 2005;47(5):447–452
   PubMed Web of Science ®Google Scholar
• . Gill GV, Woodward A, Casson IF, Weston PJ. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes—the ‘dead in bed’ syndrome revisited. Diabetologia. 2009;52(1):42–45
   PubMed Web of Science ®Google Scholar
• . Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301(15):1565–1572
   PubMed Web of Science ®Google Scholar
• . Bolli GB. Hypoglycaemia unawareness. Diabetes Metab. 1997;23( suppl 3):29–35
   PubMed Web of Science ®Google Scholar
• . Gold AE, Macleod KM, Frier BM. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 1994;17(7):697–703
   PubMed Web of Science ®Google Scholar
• . Saleh M, Grunberger G. Hypoglycemia: an excuse for poor glycemic control? Clinical Diabetes. 2001;19(4):161–167
   Google Scholar
• . Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care. 2001;24(11):1858–1862
   PubMed Web of Science ®Google Scholar
• . Cox DJ, Kovatchev BP, Anderson SM, Clarke WL, Gonder-Frederick LA. Type 1 diabetic drivers with and without a history of recurrent hypoglycemia-related driving mishaps: Physiological and performance differences during euglycemia and the induction of hypoglycemia. Diabetes Care. 2010;33(11):2430–2435
   PubMed Web of Science ®Google Scholar
• . Fanelli CG, Epifano L, Rambotti AM,. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes. 1993;42(11):1683–1689
   PubMed Web of Science ®Google Scholar
• . Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes. 2005;54(12):3592–3601
   PubMed Web of Science ®Google Scholar
• . Woodward A, Weston P, Casson IF, Gill GV. Nocturnal hypoglycaemia in type 1 diabetes—frequency and predictive factors. QJM. 2009;102(9):603–607
   PubMed Web of Science ®Google Scholar
• . Porter PA, Keating B, Byrne G, Jones TW. Incidence and predictive criteria of nocturnal hypoglycemia in young children with insulin-dependent diabetes mellitus. J Pediatr. 1997;130(3):366–372
   PubMed Web of Science ®Google Scholar
• . Chico A, Vidal-Rios P, Subira M, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care. 2003;26(4):1153–1157
   PubMed Web of Science ®Google Scholar
• . ; Action to Control Cardiovascular Risk in Diabetes Study GroupGerstein HC, Miller ME, Byington RP,. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24):2545–2559
   PubMed Web of Science ®Google Scholar
• . Bonds DE, Miller ME, Bergenstal RM,. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010;340:b4909
   PubMed Web of Science ®Google Scholar
• . Cox DJ, Irvine A, Gonder-Frederick L, Nowacek G, Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care. 1987;10(5):617–621
   PubMed Web of Science ®Google Scholar
• . Irvine AA, Cox D, Gonder-Frederick L. Fear of hypoglycemia: relationship to physical and psychological symptoms in patients with insulin-dependent diabetes mellitus. Health Psychol. 1992;11(2):135–138
   PubMed Web of Science ®Google Scholar
• . Polonsky WH, Davis CL, Jacobson AM, Anderson BJ. Hyperglycaemia, hypoglycaemia, and blood glucose control in diabetes: symptom perceptions and treatment strategies. Diabet Med. 1992;9(2):120–125
   PubMed Web of Science ®Google Scholar
• . Wild D, von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Educ Couns. 2007;68(1):10–15
   PubMed Web of Science ®Google Scholar
• . Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005;28(10):2543–2545
   PubMed Web of Science ®Google Scholar
• . Tupola S, Rajantie J, Akerblom HK. Experience of severe hypoglycaemia may influence both patient's and physician's subsequent treatment policy of insulin-dependent diabetes mellitus. Eur J Pediatr. 1998;157(8):625–627
   PubMed Web of Science ®Google Scholar
• . American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care. 2010;33( suppl 1):S11–S61
   PubMed Web of Science ®Google Scholar
• . Munshi MN, Segal AR, Suhl E,. Frequent hypoglycemia among elderly patients with poor glycemic control. Arch Intern Med. 2011;171(4):362–364
   PubMedGoogle Scholar
• . Cranston I, Lomas J, Maran A, Macdonald I, Amiel SA. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes. Lancet. 1994;344(8918):283–287
   PubMed Web of Science ®Google Scholar
• . Fanelli C, Pampanelli S, Epifano L,. Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM. Diabetologia. 1994;37(12):1265–1276
   PubMed Web of Science ®Google Scholar
• . Hirsch IB. Insulin analogues. N Eng J Med. 2005;352(2):174–183
   PubMed Web of Science ®Google Scholar
• . Gough SC. A review of human and analogue insulin trials. Diabetes Res Clin Pract. 2007;77(1):1–15
   PubMed Web of Science ®Google Scholar
• . Heller S, Koenen C, Bode B. Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial. Clin Ther. 2009;31(10):2086–2097
   PubMed Web of Science ®Google Scholar
• . Garg SK, Carmain JA, Braddy KC,. Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes. Diabet Med. 1996;13(1):47–52
   PubMed Web of Science ®Google Scholar
• . Bode BW, Strange P. Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes. Diabetes Care. 2001;24(1):69–72
   PubMed Web of Science ®Google Scholar
• . Bode B, Weinstein R, Bell D,. Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion: a randomized study in type 1 diabetes. Diabetes Care. 2002;25(3):439–444
   PubMed Web of Science ®Google Scholar
• . Holman RR, Thorne KI, Farmer AJ,; 4-T Study Group. Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med. 2007;357(17):1716–1730
   PubMed Web of Science ®Google Scholar
• . Raskin P, Allen E, Hollander P,. Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care. 2005;28(2):260–265
   PubMed Web of Science ®Google Scholar
• . Halimi S, Raskin P, Liebl A, Kawamori R, Fulcher G, Yan G. Efficacy of biphasic insulin aspart in patients with type 2 diabetes. Clin Ther. 2005;27( suppl B):S57–S74
   PubMed Web of Science ®Google Scholar
• . Dailey G, Strange P, Riddle M. Reconsideration of severe hypoglycemic events in the treat-to-target trial. Diabetes Technol Ther. 2009;11(8):477–479
   PubMed Web of Science ®Google Scholar
• . Unger J, Nadeau DA. Defining the role of incretin mimetic therapy in the management of type 2 diabetes. J Fam Pract. 2007;56( 12 suppl new):S4–S10
   Google Scholar
• . Herman WH, Ilag LL, Johnson SL,. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care. 2005;28(7):1568–1573
   PubMed Web of Science ®Google Scholar
• . Wainstein J, Metzger M, Boaz M,. Insulin pump therapy vs. multiple daily injections in obese type 2 diabetic patients. Diabet Med. 2005;22(8):1037–1046
   PubMed Web of Science ®Google Scholar
• . Rodbard HW, Blonde L, Braithwaite SS,. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13( suppl 1):1–68
   PubMedGoogle Scholar
• . International Diabetes Federation Guideline Development Committee. Guideline for management of postmeal glucose. 2007. http://www.idf.org. Accessed January 12, 2011
   Google Scholar
• . Dailey G. Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements. Mayo Clin Proc. 2007;82(2):229–235
   PubMed Web of Science ®Google Scholar
• . National Institute of Diabetes and Digestive and Kidney Diseases. Continuous glucose monitoring. 2010. http://diabetes.niddk.nih.gov/dm/pubs/glucosemonitor/index.htm. Accessed December 20, 2010
   Google Scholar
• . Ryan EA, Germsheid J. Use of continuous glucose monitoring system in the management of severe hypoglycemia. Diabetes Technol Ther. 2009;11(10):635–639
   PubMed Web of Science ®Google Scholar
• . Geiger MC, Ferreira JV, Hafiz MM,. Evaluation of metabolic control using a continuous subcutaneous glucose monitoring system in patients with type 1 diabetes mellitus who achieved insulin independence after islet cell transplantation. Cell Transplant. 2005;14(2–3):77–84
   PubMed Web of Science ®Google Scholar
• . Bailey TS, Zisser HC, Garg SK. Reduction in hemoglobin A1C with real-time continuous glucose monitoring: results from a 12-week observational study. Diabetes Technol Ther. 2007;9(3):203–210
   PubMed Web of Science ®Google Scholar
• . Garg S, Jovanovic L. Relationship of fasting and hourly blood glucose levels to HbA1c values: safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care. 2006;29(12):2644–2649
   PubMed Web of Science ®Google Scholar
• . Garg S, Zisser H, Schwartz S,. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care. 2006;29(1):44–50
   PubMed Web of Science ®Google Scholar
• . ; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study GroupTamborlane WV, Beck RW, Bode BW,. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359(14):1464–1476
   PubMed Web of Science ®Google Scholar
• . ; Juvenile Diabetes Research Federation Continuous Glucose Monitoring Study GroupBeck RW, Hirsch IB, Laffel L,. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care. 2009;32(8):1378–1383
   PubMed Web of Science ®Google Scholar
• . ; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study GroupBode B, Beck RW, Xing D,. Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes. Diabetes Care. 2009;32(11):2047–2049
   PubMed Web of Science ®Google Scholar
• . Battelino T, Phillip M, Bratina N, Nimri R, Oskarsson P, Bolinder J. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care. 2011;34(4):795–800
   PubMed Web of Science ®Google Scholar
• . Deiss D, Bolinder J, Riveline JP,. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29(12):2730–2732
   PubMed Web of Science ®Google Scholar
• . Hirsch IB, Abelseth J, Bode BW,. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther. 2008;10(5):377–383
   PubMed Web of Science ®Google Scholar
• . Cemeroglu AP, Stone R, Kleis L, Racine MS, Postellon DC, Wood MA. Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients' and caregivers' perception of benefit. Pediatr Diabetes. 2010;11(3):182–187
   PubMed Web of Science ®Google Scholar
• . Nardacci EA, Bode BW, Hirsch IB. Individualizing care for the many: the evolving role of professional continuous glucose monitoring systems in clinical practice. Diabetes Educ. 2010;36( suppl 1):4S–19S
   Web of Science ®Google Scholar
• . Guerci B, Floriot M, Bohme P,. Clinical performance of CGMS in type 1 diabetic patients treated by continuous subcutaneous insulin infusion using insulin analogs. Diabetes Care. 2003;26(3):582–589
   PubMed Web of Science ®Google Scholar
• . Hirsch IB, Bode BW, Garg S,; Insulin Aspart CSII/MDI Comparison Study Group. Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII. Diabetes Care. 2005;28(3):533–538
   PubMed Web of Science ®Google Scholar
• . White NH. The contributions of medications to hypoglycemic unawareness. Diabetes Spectrum. 2007;20(2):77–80
   Google Scholar
• . Learning About Diabetes. Low blood sugar [patient handout]. 2010. http://www.learningaboutdiabetes.org. Accessed December 20, 2010
   Google Scholar